
Fenofibrate
Fenofibrate capsules are indicated as adjunctive therapy to diet for the reduction of LDL-C. Total-C. Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed…
Fenofibrate capsules are indicated as adjunctive therapy to diet for the reduction of LDL-C. Total-C. Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed…
Trilipix is a peroxisome proliferator receptor alpha (PPARalpha) activator indicated: In combination with a statin to reduce TG and increase HDL-C in patients with mixed dyslipidemia and CHD or a CHD risk equivalent who are on optimal statin therapy…
FIBRICOR is a peroxisome proliferator receptor alpha (PPARalpha) activator indicated as an adjunct to diet: to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (>= 500 mg/dL) (1.1). to reduce elevated total…
FIBRICOR is a peroxisome proliferator receptor alpha (PPARalpha) activator indicated as an adjunct to diet: to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (>= 500 mg/dL) (1.1). to reduce elevated total…
Fenofibric acid tablets are a peroxisome proliferator receptor alpha (PPARalpha) activator indicated as an adjunct to diet: to reduce triglyceride (TG) levels in adult patients with…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2021. All Rights Reserved.